$ICPT News
This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 4:29 p.m. Jan. 10, 2014 - Sue Chang
Macy’s up on restructuring; Apple and Samsung to talk 4:40 p.m. Jan. 9, 2014 - Sue Chang
Stock record? Intercept Pharma up nearly 300% on drug test results 2:14 p.m. Jan. 9, 2014 - Russ Britt
Intercept Pharma, Kythera take off in IPOs 10:53 a.m. Oct. 11, 2012 - MarketWatch.com
Intercept Pharma, Kythera take off in IPOs 10:34 a.m. Oct. 11, 2012 - MarketWatch.com
In the IPO desert, Thursday brings rain 9:42 a.m. Oct. 11, 2012 - MarketWatch
Intercept Pharma 5M-share IPO prices at high end 7:06 a.m. Oct. 11, 2012 - MarketWatch.com
Stocks to watch Thursday: Ruby Tuesday, Realogy 5:44 a.m. Oct. 11, 2012 - MarketWatch
5 Dumbest Things on Wall Street This Week 7:00 a.m. Today - TheStreet.com
3 Critical Factors For Intercept Bulls Now 4:02 a.m. Jan. 16, 2014 - Seeking Alpha
Athersys: Why Did Shareholders Come Knocking At The Door Once Again? 3:15 p.m. Jan. 15, 2014 - Seeking Alpha
Intercept Pharma cools off after presentation 11:04 a.m. Jan. 15, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Intercept Pharmaceuticals (ICPT) 9:45 a.m. Jan. 15, 2014 - TheStreet.com
Intercept rallies ahead of conference, BofA defends lofty target 8:29 a.m. Jan. 15, 2014 - Seeking Alpha
Hot New Biotech Knows Roller-Coaster Feeling 7:49 p.m. Jan. 14, 2014 - WSJ.com
Intercept Pharmaceuticals Inc (ICPT): Today's Featured Drugs Laggard 5:01 p.m. Jan. 14, 2014 - TheStreet.com
Intercept Pharma falls again as article strikes cautious tone 11:07 a.m. Jan. 14, 2014 - Seeking Alpha
The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians 10:20 a.m. Jan. 14, 2014 - Seeking Alpha
ICPT: Time to Catch a Rising Star With Intercept Stock? 8:34 a.m. Jan. 14, 2014 - InvestorPlace.com
SA PRO: Top Long And Short Ideas, Monday January 13 7:30 a.m. Jan. 14, 2014 - Seeking Alpha
'Fast Money' Recap: The Economy and the Market 5:00 a.m. Jan. 14, 2014 - TheStreet.com
XBI – Be Careful With This Biotech ETF After Its Violent Breakout 3:00 a.m. Jan. 14, 2014 - InvestorPlace.com
Biotech Stocks Back On Top, Led By Biogen, Alexion 5:07 p.m. Jan. 13, 2014 - Investors Business Daily
Watch Out for Mr. Downside 4:18 p.m. Jan. 13, 2014 - RealMoney.com
Weak Action Threatens to Spread 1:10 p.m. Jan. 13, 2014 - RealMoney.com
Summer Street shrugs off Intercept Pharma LDL concerns 11:58 a.m. Jan. 13, 2014 - Seeking Alpha
A Sleepy Start to the Week 10:56 a.m. Jan. 13, 2014 - RealMoney.com
Good News Continues to Roll in for CytRx 9:59 a.m. Jan. 13, 2014 - Wall St. Cheat Sheet
Harwood Feffer LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 8:00 p.m. Jan. 15, 2014 - PR Newswire - PRF
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 2:03 p.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 11:19 a.m. Jan. 13, 2014 - ACCESSWIRE
Intercept Reports Additional Details About FLINT Trial Provided by NIDDK 6:06 p.m. Jan. 12, 2014 - GlobeNewswire
Intercept to Present at the J.P. Morgan Healthcare Conference 6:31 p.m. Jan. 10, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology 7:33 a.m. Jan. 9, 2014 - GlobeNewswire
Intercept Pharmaceuticals to Provide 2013 Update on Clinical Programs for Obeticholic Acid on January 9 4:05 p.m. Jan. 2, 2014 - GlobeNewswire
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
INTERCEPT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Intercept Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 6:31 p.m. Dec. 9, 2013 - PR Newswire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results 6:05 a.m. Nov. 14, 2013 - PR Newswire
Trial Results Presentations, Public Offerings, Acquisitions and Extension Study Results - Research Report on Medtronic, Steris, Intercept, Wright, and Synageva 7:00 a.m. Oct. 23, 2013 - PR Newswire
Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders 8:02 p.m. Oct. 8, 2013 - PR Newswire
Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors 7:30 a.m. Oct. 4, 2013 - GlobeNewswire
Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA 7:00 a.m. Oct. 4, 2013 - PR Newswire
Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting 3:05 p.m. Oct. 1, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results 5:00 a.m. Aug. 13, 2013 - PR Newswire
Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference 5:00 a.m. Aug. 5, 2013 - PR Newswire
This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 4:29 p.m. Jan. 10, 2014 - Sue Chang
Macy’s up on restructuring; Apple and Samsung to talk 4:40 p.m. Jan. 9, 2014 - Sue Chang
Stock record? Intercept Pharma up nearly 300% on drug test results 2:14 p.m. Jan. 9, 2014 - Russ Britt
Intercept Pharma, Kythera take off in IPOs 10:53 a.m. Oct. 11, 2012 - MarketWatch.com
Intercept Pharma, Kythera take off in IPOs 10:34 a.m. Oct. 11, 2012 - MarketWatch.com
In the IPO desert, Thursday brings rain 9:42 a.m. Oct. 11, 2012 - MarketWatch
Intercept Pharma 5M-share IPO prices at high end 7:06 a.m. Oct. 11, 2012 - MarketWatch.com
Stocks to watch Thursday: Ruby Tuesday, Realogy 5:44 a.m. Oct. 11, 2012 - MarketWatch
5 Dumbest Things on Wall Street This Week 7:00 a.m. Today - TheStreet.com
3 Critical Factors For Intercept Bulls Now 4:02 a.m. Jan. 16, 2014 - Seeking Alpha
Athersys: Why Did Shareholders Come Knocking At The Door Once Again? 3:15 p.m. Jan. 15, 2014 - Seeking Alpha
Intercept Pharma cools off after presentation 11:04 a.m. Jan. 15, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Intercept Pharmaceuticals (ICPT) 9:45 a.m. Jan. 15, 2014 - TheStreet.com
Intercept rallies ahead of conference, BofA defends lofty target 8:29 a.m. Jan. 15, 2014 - Seeking Alpha
Hot New Biotech Knows Roller-Coaster Feeling 7:49 p.m. Jan. 14, 2014 - WSJ.com
Intercept Pharmaceuticals Inc (ICPT): Today's Featured Drugs Laggard 5:01 p.m. Jan. 14, 2014 - TheStreet.com
Intercept Pharma falls again as article strikes cautious tone 11:07 a.m. Jan. 14, 2014 - Seeking Alpha
The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians 10:20 a.m. Jan. 14, 2014 - Seeking Alpha
ICPT: Time to Catch a Rising Star With Intercept Stock? 8:34 a.m. Jan. 14, 2014 - InvestorPlace.com
SA PRO: Top Long And Short Ideas, Monday January 13 7:30 a.m. Jan. 14, 2014 - Seeking Alpha
'Fast Money' Recap: The Economy and the Market 5:00 a.m. Jan. 14, 2014 - TheStreet.com
XBI – Be Careful With This Biotech ETF After Its Violent Breakout 3:00 a.m. Jan. 14, 2014 - InvestorPlace.com
Biotech Stocks Back On Top, Led By Biogen, Alexion 5:07 p.m. Jan. 13, 2014 - Investors Business Daily
Watch Out for Mr. Downside 4:18 p.m. Jan. 13, 2014 - RealMoney.com
Weak Action Threatens to Spread 1:10 p.m. Jan. 13, 2014 - RealMoney.com
Summer Street shrugs off Intercept Pharma LDL concerns 11:58 a.m. Jan. 13, 2014 - Seeking Alpha
A Sleepy Start to the Week 10:56 a.m. Jan. 13, 2014 - RealMoney.com
Good News Continues to Roll in for CytRx 9:59 a.m. Jan. 13, 2014 - Wall St. Cheat Sheet
Harwood Feffer LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 8:00 p.m. Jan. 15, 2014 - PR Newswire - PRF
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 2:03 p.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 11:19 a.m. Jan. 13, 2014 - ACCESSWIRE
Intercept Reports Additional Details About FLINT Trial Provided by NIDDK 6:06 p.m. Jan. 12, 2014 - GlobeNewswire
Intercept to Present at the J.P. Morgan Healthcare Conference 6:31 p.m. Jan. 10, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology 7:33 a.m. Jan. 9, 2014 - GlobeNewswire
Intercept Pharmaceuticals to Provide 2013 Update on Clinical Programs for Obeticholic Acid on January 9 4:05 p.m. Jan. 2, 2014 - GlobeNewswire
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
INTERCEPT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Intercept Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 6:31 p.m. Dec. 9, 2013 - PR Newswire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results 6:05 a.m. Nov. 14, 2013 - PR Newswire
Trial Results Presentations, Public Offerings, Acquisitions and Extension Study Results - Research Report on Medtronic, Steris, Intercept, Wright, and Synageva 7:00 a.m. Oct. 23, 2013 - PR Newswire
Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders 8:02 p.m. Oct. 8, 2013 - PR Newswire
Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors 7:30 a.m. Oct. 4, 2013 - GlobeNewswire
Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA 7:00 a.m. Oct. 4, 2013 - PR Newswire
Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting 3:05 p.m. Oct. 1, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results 5:00 a.m. Aug. 13, 2013 - PR Newswire
Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference 5:00 a.m. Aug. 5, 2013 - PR Newswire
